Cooper Companies (COO) Non-Current Assets (2009 - 2026)
Cooper Companies (COO) posted Non-Current Assets of $10.2 billion for Q2 2026, down 1.05% on a QoQ basis from $10.3 billion in Q1 2026, and down 1.02% year-over-year from $10.3 billion in Q2 2025.
Analysis
Cooper Companies (COO) Non-Current Assets (2009 - 2026) Analysis & Trends
Cooper Companies has reported Non-Current Assets for 18 years, with the latest figure at $10.2 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 1.02% year-over-year to $10.2 billion in Q2 2026; TTM through Apr 2026 was $41.0 billion, a 0.17% change from a year earlier, with the FY2025 full-year figure at $10.3 billion, down 0.73% from the prior year.
- Non-Current Assets was $10.2 billion for Q2 2026 at Cooper Companies, down from $10.3 billion in the prior quarter.
- The five-year high for Non-Current Assets was $10.4 billion in Q4 2024, with the low at $9.9 billion in Q2 2023.
- Average Non-Current Assets over 5 years is $10.1 billion, with a median of $10.2 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Non-Current Assets surged 30.69% in 2022, then declined 1.02% in 2026.
- Over 5 years, Non-Current Assets stood at $10.0 billion in 2022, then slipped by 0.05% to $10.0 billion in 2023, then rose by 4.12% to $10.4 billion in 2024, then dropped by 0.73% to $10.3 billion in 2025, then slipped by 1.03% to $10.2 billion in 2026.
- The last three Non-Current Assets figures came in at $10.2 billion (Q2 2026), $10.3 billion (Q1 2026), and $10.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 10.18 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 10.18 Bn |
| Jan 31, 2026 | 10.29 Bn |
| Oct 31, 2025 | 10.29 Bn |
| Jul 31, 2025 | 10.24 Bn |
| Apr 30, 2025 | 10.29 Bn |
| Jan 31, 2025 | 10.24 Bn |
| Oct 31, 2024 | 10.36 Bn |
| Jul 31, 2024 | 10.18 Bn |
| Apr 30, 2024 | 10.19 Bn |
| Jan 31, 2024 | 10.24 Bn |
| Oct 31, 2023 | 9.95 Bn |
| Jul 31, 2023 | 9.99 Bn |
| Apr 30, 2023 | 9.94 Bn |
| Jan 31, 2023 | 9.98 Bn |
| Oct 31, 2022 | 9.96 Bn |
| Jul 31, 2022 | 9.95 Bn |
| Apr 30, 2022 | 10.04 Bn |
| Jan 31, 2022 | 9.96 Bn |
| Oct 31, 2021 | 8.14 Bn |
| Jul 31, 2021 | 8.14 Bn |